Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for the development of a cell-based therapy for diabetes. Ongoing research at Semma Therapeutics is focused on combining these proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. Semma Therapeutics is working to bring this new therapeutic option to the clinic and improve the lives of patients with diabetes.

Semma Therapeutics

Executive Director

Executive Director, Exploratory Biology

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.

Sana Biotechnology

Executive Director, PSC Process Development

Unlocking the full potential of our most vulnerable seniors with empathy and love.

At WelbeHealth, we envision a world in which every human being is able to participate fully in life through their final days. We serve frail seniors through a model of comprehensive medical and social care called PACE (Program of All-Inclusive Care for the Elderly), helping our participants live better, longer, and more independently. Founded by a seasoned group of physician entrepreneurs, our leadership team hails from leading payer and provider organizations such as GoHealth Urgent Care, BAYADA Home Health, AirStrip Technologies, Evolent Health, and On Lok. With funding from leading venture capital firms, we're looking for team members who are inspired to help us deliver on our mission of unlocking the full potential of the most vulnerable seniors in our communities. Our colleagues are energized by working in diverse groups toward our shared purpose, are eager to drive groundbreaking innovations, and have the courage to care for our participants with empathy and love.

WelbeHealth

Executive Director Launch

Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.

Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. These potential therapies could provide novel strategies for the treatment and management of a wide range of tumor types.

Kite Pharma

Executive Director, Medical Affairs – Multiple Myeloma Global Asset Lead

Executive Director, Medical Affairs – Tecartus Global Asset Lead

immuneering

Executive Director/CMC

Immuneering is a bioinformatics company that develops new medicines unlikely to be found by traditional drug discovery methods.

Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. It has more than a decade of experience in translational bioinformatics and generating insights into drug mechanisms of action and patient treatment responses.

Immuneering

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time. The company was founded in 2018 and is headquartered in Somerville, Massachusetts.

Location

Company Stage

Age of Data

Experience

Industry

Company

Executive Director

Semma Therapeutics

$256k - $384k

$256,000 - $384,000

Sana Biotechnology

$283k - $333k

$282,500 - $332,500

WelbeHealth

$170k - $223k

$170,000 - $223,299

Kite Pharma

N/A

N/A

immuneering

N/A

N/A

Immuneering

N/A

N/A

Generate Biomedicines

N/A

N/A